Life sciences and healthcare

We are a multi-jurisdiction, cross-practice sector team trusted by the world’s leading life sciences and healthcare companies.

Our global team works with some of the most innovative and successful life sciences and healthcare companies. We combine scientific knowledge, legal expertise and the resources of an elite global firm to deliver innovative and value-enhancing solutions which enable our clients to achieve their strategic goals.

We offer our clients a fully comprehensive service including: 

• M&A / Corporate: Recognised for doing the most complex, cross-border deals with broad experience across the industry spectrum including pharmaceutical and biotech companies, devices, diagnostics, API, CRO, CMO/CDMO, marketing sales and distribution companies and other pharma services players.
• Disputes: One of the largest practices globally with over 750 fee earners. We are experienced in disputes arising from commercial agreements and collaborations in the sector, including R&D, licensing, supply, distribution and co-promotion. Our top-tier class actions team brings experience in defending life sciences companies in complex, multi-jurisdictional litigation.
• Intellectual property: Globally recognised as market leaders, particularly in patent litigation, we having acted on many of the highest-selling pharmaceutical products and most significant medical devices disputes in the market.
• Regulatory: We advise development-stage, speciality and established global life sciences and healthcare companies on complex, commercially significant regulatory issues across the life cycle of pharmaceutical and biotech products and medical devices. Our work spans both contentious and non-contentious matters, from product development and regulatory compliance to the optimisation of IP and regulatory rights, exclusivities and incentives, market access strategy, disputes, litigation and regulatory enforcement.
• Competition: A sector specialist team working alongside our corporate and disputes teams across the full spectrum of competition law matters, including merger control, FDI, cartels and investigations, agreements and partnerships, competition litigation and compliance, state aid and subsidy control.
• Corporate crime and investigations: Our global white-collar crime and government investigations team advise clients in the sector extensively on corporate criminal and regulatory matters (including in relation to internal and government-facing investigations, defending clients with enforcement actions, and helping to develop and implement compliance programmes).